Quiver Bioscience-preview

Quiverbioscience

Quiver Bioscience

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.quiverbioscience.com/

Last Round

Grant

May 5, 2026

Total Funding Raised

$3.65M

Company Overview

Quiver Bioscience is a biotechnology company that offers a neuroscience research platform to accelerate the discovery of therapeutics for central nervous system disorders.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Infrastructure

Keywords

drug discovery platformAI drug discoveryCNS drug discoverydrug target identificationbiological foundation modelsall-optical electrophysiologyphenotypic screeningpatient-derived cell modelsiPSC modelsneurodevelopmental disorderschronic pain therapeuticshigh-throughput screeningpreclinical researchbiotech AIdrug safety assessmentin-silico drug discoveryASO therapeuticsorganoid intelligence

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Quiver Bioscience Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Quiver Bioscience Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	May 5, 2026
Strategic	Apr 13, 2026
Grant	Sep 18, 2025
Grant	Jul 2, 2025
Grant	Jul 1, 2025
Grant	Mar 19, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Graham T. Dempsey

Founder And Chief Executive Officer

Founding Team

Owen McManus

Consulting Chief Technology Officer

Executive Team

Quiver Bioscience Investors

Notable investors and investment history

Investor	Rounds
National Cancer Institute	Grant
CURE Epilepsy	Grant
NIH Helping to End Addiction Long-term (HEAL) Initiative	Grant
NIH RADx	Grant
FRAXA Research Foundation	Grant
National Institute of Neurological Disorders and Stroke	Grant
Exponential Capital Management	M&A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 5, 2026
$9.3M grant from National Institute of Neurological Disorders and Stroke and NIH HEAL Initiative.
Apr 13, 2026
Completed a strategic funding round.

View all signals

Quiver Bioscience Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Quiver Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Quiver Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Employee Range44

Year Founded2013

Last FundingMay 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.